AAAAAA

   
Results: 1-9 |
Results: 9
Hydroxyls nests in defective silicalites and strained structures derived upon dehydroxylation: vibrational properties and theoretical modelling
Authors: Bordiga, S Ugliengo, P Damin, A Lamberti, C Spoto, G Zecchina, A Spano, G Buzzoni, R Dalloro, L Rivetti, F
Citation: S. Bordiga et al., Hydroxyls nests in defective silicalites and strained structures derived upon dehydroxylation: vibrational properties and theoretical modelling, TOP CATAL, 15(1), 2001, pp. 43-52
Characterisation of defective silicalites
Authors: Bordiga, S Roggero, I Ugliengo, P Zecchina, A Bolis, V Artioli, G Buzzoni, R Marra, G Rivetti, F Spano, G Lamberti, C
Citation: S. Bordiga et al., Characterisation of defective silicalites, J CHEM S DA, (21), 2000, pp. 3921-3929
New clinical trials for the treatment of neuroendocrine tumors
Authors: Bajetta, E Bichisao, E Artale, S Celio, L Ferrari, L Di Bartolomeo, M Zilembo, N Stani, SC Buzzoni, R
Citation: E. Bajetta et al., New clinical trials for the treatment of neuroendocrine tumors, Q J NUCL M, 44(1), 2000, pp. 96-101
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors
Authors: Bajetta, E Zilembo, N Bichisao, E Martinetti, A Buzzoni, R Pozzi, P Bidoli, P Ferrari, L Celio, L
Citation: E. Bajetta et al., Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors, ANN ONCOL, 11(8), 2000, pp. 1017-1022
Ovarian ablation for premenopausal early-stage breast cancer: An update
Authors: Celio, L Bajetta, E Toffolatti, L Catena, L Beretta, E Buzzoni, R
Citation: L. Celio et al., Ovarian ablation for premenopausal early-stage breast cancer: An update, TUMORI, 86(3), 2000, pp. 191-194
Regeneration of deactivated beta-zeolite by coke oxidation
Authors: Genoni, F Casati, GP Palmery, S Spano, G Buzzoni, R Girotti, G Rivetti, F
Citation: F. Genoni et al., Regeneration of deactivated beta-zeolite by coke oxidation, J THERM ANA, 56(1), 1999, pp. 297-303
Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: Results of a feasibility study
Authors: Bajetta, E Di Bartolomeo, M Stani, SC Artale, S Ricci, SB Bozzetti, F Mazzaferro, V Toffolatti, L Buzzoni, R
Citation: E. Bajetta et al., Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: Results of a feasibility study, INT J RAD O, 45(2), 1999, pp. 285-289
Integrated treatment with doxifluridine and radiotherapy in recurrent or primary unresectable rectal cancer. A feasibility study
Authors: Di Bartolomeo, M Bajetta, E Buzzoni, R Bozzetti, F Artale, S Valvo, F
Citation: M. Di Bartolomeo et al., Integrated treatment with doxifluridine and radiotherapy in recurrent or primary unresectable rectal cancer. A feasibility study, TUMORI, 85(3), 1999, pp. 211-213
Premenopausal breast cancer patients treated with a gonadotropin-releasinghormone analog alone or in combination with an aromatase inhibitor: A comparative endocrine study
Authors: Celio, L Martinetti, A Ferrari, L Buzzoni, R Mariani, L Miceli, R Seregni, E Procopio, G Cassata, A Bombardieri, E Bajetta, E
Citation: L. Celio et al., Premenopausal breast cancer patients treated with a gonadotropin-releasinghormone analog alone or in combination with an aromatase inhibitor: A comparative endocrine study, ANTICANC R, 19(3B), 1999, pp. 2261-2268
Risultati: 1-9 |